Misappropriation and Diversion of Resident Oxycodone Medications
Summary
The deficiency involves the facility’s failure to protect residents from misappropriation of their medications, specifically controlled substances (oxycodone) prescribed for pain management. Five residents with chronic pain and multiple comorbidities had oxycodone orders and care plans directing staff to administer scheduled and PRN pain medications and to monitor effectiveness. Documentation showed that these residents generally reported their pain as controlled or at baseline, and observations on various dates confirmed that they denied uncontrolled or increased pain and voiced no concerns. However, during a routine shift-change narcotic count, nursing staff discovered that multiple oxycodone blister cards on two medication carts had been tampered with and that the oxycodone tablets had been removed and replaced with other medications, including loratadine and Vitamin B‑12. For one resident with mild cognitive impairment and chronic pain related to spinal fusion and spondylosis, an oxycodone 5 mg PRN order had been in place, but later review of the narcotic count sheet and medication card showed that there was no oxycodone card present in the cart. Another cognitively intact resident with COPD, heart failure, renal failure, and chronic pain had two oxycodone 5 mg cards that appeared intact and untampered when observed, but the facility’s diversion matrix later identified that 70 oxycodone 5 mg tablets from two cards assigned to this resident had been missing or replaced. A third resident on hospice with chronic pain and multiple serious diagnoses, including emphysema, heart failure, renal failure, dementia, and schizophrenia, had an oxycodone 5 mg PRN order; one packet of oxycodone 5 mg tablets was present and appeared untampered when observed, yet the diversion matrix documented that 11 tablets from one card had been missing or replaced. Another cognitively intact resident with chronic pain from nerve damage after a stroke, who received both scheduled and PRN oxycodone 5 mg, had three packets of oxycodone 5 mg tablets present in the cart that did not appear tampered with at the time of observation, but the facility’s internal review identified that 55 tablets from one card had been missing or replaced. A fifth resident with paraplegia, chronic pain syndrome, and multiple psychiatric diagnoses had an oxycodone 10 mg PRN order; two packets of oxycodone 10 mg tablets were present in the cart and appeared intact, with pink, scored tablets. However, earlier that same day, the DON and staff had identified that this resident’s oxycodone 10 mg card had been tampered with and that all oxycodone tablets in that card had been replaced with OTC pink Vitamin B‑12 tablets, with each blister cavity resealed using small pieces of paper tape. Overall, the facility’s investigation and medication diversion matrix documented that seven oxycodone blister cards assigned to these five residents had been altered, with a total of 279 oxycodone tablets missing and replaced with non‑narcotic medications, constituting misappropriation of resident medications. The facility’s internal investigation, based on pharmacy delivery records, MARs, narcotic control sheets, staffing schedules, and the physical condition of the blister cards, determined that the tampering involved puncturing the blisters, removing oxycodone tablets, and resealing the backs of the cards with paper tape so that the cards appeared intact during routine counts. The investigation concluded that one RN, who had begun working independently on the medication cart where several of the affected residents’ medications were stored, had consistent access to the narcotic supplies during the period when the discrepancies occurred. Law enforcement interviews documented that this nurse ultimately admitted to removing oxycodone tablets from the residents’ blister cards over a period of time, swapping them with loratadine and other OTC tablets, and taking more than one hundred oxycodone tablets, which she stated were later disposed of. These actions resulted in the wrongful use and diversion of residents’ prescribed oxycodone, in violation of the requirement to protect residents from misappropriation of their belongings or money, including medications.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



